These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39077066)

  • 1. Characterization of
    Grant LR; Apodaca K; Deshpande L; Kimbrough JH; Hayford K; Yan Q; Mendes R; Cané A; Gessner BD; Arguedas A
    Front Pediatr; 2024; 12():1383748. PubMed ID: 39077066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.
    Kawaguchiya M; Urushibara N; Aung MS; Ito M; Takahashi A; Habadera S; Kobayashi N
    J Infect Public Health; 2020 Aug; 13(8):1094-1100. PubMed ID: 32446777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011-20.
    Schellenberg JJ; Adam HJ; Baxter MR; Karlowsky JA; Golden AR; Martin I; Demczuk W; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2023 May; 78(Suppl 1):i37-i47. PubMed ID: 37130588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children.
    Ryman J; Sachs JR; Yee KL; Banniettis N; Weaver J; Weiss T
    Expert Rev Vaccines; 2024; 23(1):60-68. PubMed ID: 38073483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20‑Valent Pneumococcal Conjugate Vaccine: Pediatric First Approval.
    Shirley M
    Paediatr Drugs; 2023 Sep; 25(5):613-619. PubMed ID: 37440125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in Malaysia.
    Le CF; Palanisamy NK; Mohd Yusof MY; Sekaran SD
    PLoS One; 2011; 6(5):e19547. PubMed ID: 21603602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine.
    Méroc E; Fletcher MA; Hanquet G; Slack MPE; Baay M; Hayford K; Gessner BD; Grant LR
    Microorganisms; 2023 Jul; 11(7):. PubMed ID: 37512988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotype Distribution and Antimicrobial Resistance of
    Kim GR; Kim EY; Kim SH; Lee HK; Lee J; Shin JH; Kim YR; Song SA; Jeong J; Uh Y; Kim YK; Yong D; Kim HS; Kim S; Kim YA; Shin KS; Jeong SH; Ryoo N; Shin JH
    Ann Lab Med; 2023 Jan; 43(1):45-54. PubMed ID: 36045056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococci isolated from children in community-based practice differ from isolates identified by population and laboratory-based invasive disease surveillance.
    Kaur R; Gierke R; McGee L; Gonzalez E; Kobayashi M; Pichichero M;
    J Infect Dis; 2024 Apr; ():. PubMed ID: 38591247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of Antibiotic Resistance of
    Rybak A; Levy C; Ouldali N; Bonacorsi S; Béchet S; Delobbe JF; Batard C; Donikian I; Goldrey M; Assouline J; Cohen R; Varon E
    Antibiotics (Basel); 2023 Jun; 12(6):. PubMed ID: 37370339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study.
    Pichichero M; Kaur R; Scott DA; Gruber WC; Trammel J; Almudevar A; Center KJ
    Lancet Child Adolesc Health; 2018 Aug; 2(8):561-568. PubMed ID: 30119715
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Phongsamart W; Srifeungfung S; Chatsuwan T; Rungnobhakhun P; Maleesatharn A; Chokephaibulkit K
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period.
    Kawaguchiya M; Urushibara N; Ghosh S; Kuwahara O; Morimoto S; Ito M; Kudo K; Kobayashi N
    Microb Drug Resist; 2014 Oct; 20(5):456-65. PubMed ID: 24766085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs.
    Horn M; Theilacker C; Sprenger R; von Eiff C; Mahar E; Schiffner-Rohe J; Pletz MW; van der Linden M; Scholz M
    PLoS One; 2023; 18(2):e0281261. PubMed ID: 36791091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era.
    Kaplan SL; Center KJ; Barson WJ; Ling-Lin P; Romero JR; Bradley JS; Tan TQ; Hoffman JA; Peters TR; Gurtman A; Scott DA; Trammel J; Gruber WC; Hulten KG; Mason EO
    Clin Infect Dis; 2015 May; 60(9):1339-45. PubMed ID: 25648240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility and serotype distribution of
    Dai G; Wang T; He Y; Jiang W; Sun H; Chen Z; Zhang T; Yan Y
    Transl Pediatr; 2023 Dec; 12(12):2203-2212. PubMed ID: 38197098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.
    Richter SS; Diekema DJ; Heilmann KP; Dohrn CL; Riahi F; Doern GV
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6484-9. PubMed ID: 25136018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
    Macaj M; Perdochova L; Jakubikova J
    Vaccine; 2023 Jan; 41(2):452-459. PubMed ID: 36470684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
    Grant LR; Slack MPE; Theilacker C; Vojicic J; Dion S; Reinert RR; Jodar L; Gessner BD
    Clin Infect Dis; 2023 Feb; 76(3):e1062-e1070. PubMed ID: 35789262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.